Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Other Non Operating Income (2016 - 2023)

Bio-Techne has reported Other Non Operating Income over the past 15 years, most recently at -$3.5 million for Q2 2023.

  • Quarterly results put Other Non Operating Income at -$3.5 million for Q2 2023, down 544.97% from a year ago — trailing twelve months through Jun 2023 was $47.5 million (up 210.35% YoY), and the annual figure for FY2025 was $831000.0, up 109.68%.
  • Other Non Operating Income for Q2 2023 was -$3.5 million at Bio-Techne, down from $378000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for TECH hit a ceiling of $118.0 million in Q4 2019 and a floor of -$58.3 million in Q2 2021.
  • Median Other Non Operating Income over the past 5 years was $587000.0 (2022), compared with a mean of $6.7 million.
  • Peak annual rise in Other Non Operating Income hit 2005.59% in 2019, while the deepest fall reached 25355.0% in 2019.
  • Bio-Techne's Other Non Operating Income stood at $118.0 million in 2019, then crashed by 92.47% to $8.9 million in 2020, then soared by 198.29% to $26.5 million in 2021, then tumbled by 100.28% to -$74000.0 in 2022, then crashed by 4686.49% to -$3.5 million in 2023.
  • The last three reported values for Other Non Operating Income were -$3.5 million (Q2 2023), $378000.0 (Q1 2023), and -$74000.0 (Q4 2022) per Business Quant data.